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A B S T R A C T
Some recent studies associated insulin therapy with negative cardiovascular events and shorter lifespan. SUR2A,
a KATP channel subunit, regulate cardioprotection and cardiac ageing. Here, we have tested whether glucose and
insulin regulate expression of SUR2A/KATP channel subunits and resistance to metabolic stress in heart H9c2
cells. Absence of glucose in culture media decreased SUR2A mRNA, while mRNAs of Kir6.2, Kir6.1, SUR1 and
IES SUR2B were increased. 2-deoxyglucose (50mM) decreased mRNAs of SUR2A, SUR2B and SUR1, did not
aﬀect IES SUR2A and IES SUR2B mRNAs and increased Kir6.2 mRNA. No glucose and 2-deoxyglucose (50 mM)
decreased resistance to an inhibitor of oxidative phosphorylation, DNP (10mM). 50mM glucose did not alter
KATP channel subunits nor cellular resistance to DNP (10mM). Insulin (20 ng/ml) in both physiological and high
glucose (50mM) down-regulated SUR2A while upregulating Kir6.1 and Kir6.2 (in high glucose only). Insulin
(20 ng/ml) in physiological and high glucose decreased cell survival in DNP (10mM). As opposed to Kir6.2,
infection with SUR2A resulted in titre-dependent cytoprotection. We conclude that insulin decreases resistance
to metabolic stress in H9c2 cells by decreasing SUR2A expression. Lower cardiac SUR2A levels underlie in-
creased myocardial susceptibility to metabolic stress and shorter lifespan.
1. Introduction
Diabetes mellitus is a group of metabolic diseases characterised by
hyperglycemia resulting from defects in insulin secretion, insulin ac-
tion, or both [1]. Insulin is a peptide hormone produced by pancreatic
β-cells that regulates metabolism of carbohydrates and fats [2]. Insulin
is the main therapy for type 1 diabetes (diabetes characterised by ab-
solute insulin deﬁciency) and it is also sometimes used for therapy of
type 2 diabetes (diabetes characterised by relative insulin deﬁciency
and/or insulin resistance) [3]. In cardiac muscle, insulin promotes
glucose uptake and its utilization via glycolysis and also participates in
the regulation of long-chain fatty acid uptake and protein synthesis [4].
Traditionally, insulin has been considered to be cardioprotective [5–8].
However, some more recent studies reported that insulin have cardiac
eﬀects that would not be expected from a cardioprotective hormone. In
experimental animals, it has been demonstrated that insulin inhibits
cardioprotection aﬀorded by ischaemic preconditioning [9] while in
patients with type 2 diabetes, concerns about negative cardiac events
when insulin is used as a therapeutic have been raised [10]. A large
meta-analysis suggested that insulin treatment is associated with a
signiﬁcantly higher short and long-term adverse cardiovascular out-
comes after percutaneous coronary intervention compared to diabetic
patients not treated by insulin therapy [11].
SUR2A belongs to a group of “atypical” ABC proteins as, although
possessing a structure of an ABC protein, it does not seem to mediate
transport [12]. In fact, SUR2A binds to inward rectiﬁer Kir6.2 to form
cardiac ATP-sensitive K+ (KATP) channels. Increased level of SUR2A in
the heart is demonstrated to 1) Protect myocardium against ischaemia-
reperfusion [13], 2) Protect cardiomyocytes against hypoxia and other
types of metabolic stresses [13–15], 3) Increase physical endurance
[15], 4) Counteract ageing-induced increase in myocardial suscept-
ibility towards hypoxia [16], 5) Counteract ageing-induced decrease in
physical endurance (this eﬀect could involve SUR2A eﬀect on skeletal
muscle as well, 9) and 6) Reprogram embryonic cardiomyocytes to-
wards less diﬀerentiated stem cells [17]. Recently, we have uncovered
that PI3K/Akt signalling pathway regulate SUR2A, ie. activation of
PI3K/Akt up-regulates SUR2A and confers cardioprotection [23]. In
addition to that, SUR2A expression seems to be regulated by in-
tracellular ATP [24]. As insulin activates PI3K/Akt and regulates in-
tracellular ATP by regulating metabolism of carbohydrates and fats [5],
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it is quite possible that this hormone could regulate SUR2A and, con-
sequently, cardiac resistance to stress.
H9c2 cells are well-established experimental model that is similar to
adult cardiomyocytes in crucial aspects of KATP channels structure,
regulation and function; in both cell types express all seven KATP
channel subunits [13–25] and increase in SUR2A increase numbers of
fully functional KATP channels generating cellular phenotype more re-
sistant to stress [13,14]. Signalling pathway regulating KATP channel
levels and mediating preconditioning and cardioprotection are similar
between adult cardiomyocytes and H9c2 cells [23–29]. Therefore, we
used this experimental model to examine whether glucose and insulin
regulate SUR2A levels of cellular resistance to stress.
2. Methods
2.1. H9C2 cells and treatments with viral constructs
H9C2 cells Rat embryonic heart H9c2 cells (ECACC, Salisbury, UK)
were cultured in a tissue ﬂask (at 5% CO2) containing Dulbecco's
modiﬁed Eagle's medium supplemented with 10% fetal calf serum and
2mM glutamine and 1) 5mM glucose added (control experimental
group), 2) 20 ng/ml insulin and 5mM glucose added (insulin experi-
mental group), 3) 20 ng/ml insulin and 50mM glucose added (insulin
in high glucose experimental group). The cells were cultured in in-
cubators (Galaxy, oxygen control model, RS Biotech, Irvine, UK) under
those conditions for 24 h before experiments on them were performed.
For some experiments H9C2 cells were infected with adenoviral con-
structs containing either green ﬂuorescent protein (Ad-GFP), luciferase
(Ad-luciferase), SUR2A (Ad-SUR2A) and Kir6.2 (Ad-Kir6.2). To infect
Fig. 1. No glucose and 2-deoxyglucose down-regulate SUR2A in H9c2 cells and decrease cellular resistance to metabolic stress. Bar graphs represent cycling
thresholds of the real time RT-PCR progress curves of KATP channel subunits as labelled and a bar graph (a graph on the right third row) showing a percentage of
survival in control cells and cells cultured without glucose (no glucose) or cells cultured without glucose in the presence of 50mM 2- deoxyglucose exposed to DNP
(10mM). Each bar represent mean±SEM (n=6–7). *P < 0.05 when compared to control.
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H9C2 cells, a solution of recombinant adenovirus was mixed with
culture medium, and cells were exposed to the virus with a multiplicity
of 10 viral particles/cell (for Ad-GFP and Ad-luciferase), 0.2, 1 or 5 viral
particles/cell (for Ad-Kir6.2) or 1, 3, 10, 30, 100 and 300 viral parti-
cles/cell (for Ad-SUR2A) for 48 h.
2.2. Real time RT-PCR
Total RNA was extracted from H9c2 cells using TRIZOL reagent
(Invitrogen, Carlsbad, CA) according to manufacturer recommenda-
tions. Extracted RNA was further puriﬁed by RNeasy Plus Mini Kit
(Qiagen, Crawley, UK) according to the manufacturer's instruction. Real
time RT-PCR was performed as we described earlier [13–16].
2.3. Cell survival assay
The survival of H9C2 cells were assayed using Multitox-Fluor
Multiplex Cytotoxicity Assay (Promega). Brieﬂy, H9C2 cells were plated
in 96-well plate under conditions described in “H9C2 cells” section and
after the incubation (24 h without viral constructs and 48 h with viral
constructs) cells were washed out and DMEM containing 10% FCS and
10mM 2–4 dinitrophenole (DNP) was added to each well. To measure
cell survival 6 h later, the peptide substrate (GF-AFC) that can be
cleaved only by live cells was added to the each well. Following 30min-
long incubation at 37 °C, plates were measured using 1420 Multibabel
Counter (Victor) plate reader, with excitation at 370 nm and emissions
of 480 nm. The percentage of live cells was calculated based on the
intensity of ﬂuorescence according to the manufacturer instructions.
2.4. Statistical analysis
Data are presented as mean± S.E.M, with n representing the
number of independent experiments. Mean values were compared by
the ANOVA followed by Student's t-test or by Student's t-test alone
Fig. 2. High glucose has no eﬀect on SUR2A expression in H9c2 cells and cellular resistance to metabolic stress. Bar graphs represent cycling thresholds of the real
time RT-PCR progress curves of KATP channel subunits as labelled and a bar graph (a graph on the right third row) showing a percentage of survival in cells cultured
with 5mM (control) or 50mM (high glucose) glucose exposed to DNP (10mM). Each bar represent mean±SEM (n=6–10).
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where appropriate using SigmaStat program (Jandel Scientiﬁc,
Chicago, Illinois). P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Regulation of expression of KATP channel subunits by glucose and 2-
deoxyglucose in H9c2 cells and cellular resistance to severe metabolic stress
Glucose regulates the activity of sarcolemmal KATP channels via
products of glycolysis that are direct ligands of these channels [30,31].
Here, we have tested whether low glucose and inhibition of glycolysis
regulate expression of SUR2A and other KATP channel subunits. Absence
of glucose in culture media resulted in signiﬁcant decrease of SUR2A
mRNA levels (cycling threshold was 29.67 ± 0.11 for controls and
30.92 ± 0.11 for no glucose, P < 0.001, n= 6; Fig. 1) without af-
fecting SUR2B and intra-exonic splicing (IES) SUR2A mRNA levels
(SUR2B cycling threshold was 22.88 ± 0.06 for controls and
23.15 ± 0.14 for no glucose, P= 0.112, n= 6; IES SUR2A cycling
threshold was 23.65 ± 0.17 for controls and 24.05 ± 0.21 for no
glucose, P= 0.175, n= 6, Fig. 1), but increasing Kir6.2, Kir6.1, SUR1
and IES SUR2B mRNA levels (Kir6.2 cycling threshold was
28.98 ± 0.19 for controls and 27.50 ± 0.15 for no glucose, P < 0.01,
n=6; Kir6.1 cycling threshold was 21.43 ± 0.14 for controls and
20.90 ± 0.04 for no glucose, P < 0.01, n=6; SUR1 cycling threshold
was 32.98 ± 0.18 for controls and 32.03 ± 0.16 for no glucose,
P < 0.01, n= 6; IES SUR2B cycling threshold was 31.38 ± 0.14 for
controls and 30.87 ± 0.14 for no glucose, P=0.018, n=6, Fig. 1).
On the other hand, cells cultured in the presence of 2-deoxyglucose
(50mM) had decreased mRNA levels of SUR2A, SUR2B and SUR1
(SUR2A cycling threshold was 31.62 ± 0.20 for 2-deoxyglucose,
n= 6, P < 0.01 when compared to controls; SUR2B cycling threshold
was 24.95 ± 0.18 for 2-deoxyglucose, n= 6, P < 0.01 when com-
pared to controls; SUR1 cycling threshold was 33.53 ± 0.11 for 2-
deoxyglucose, n= 6, P= 0.029 when compared to controls; Fig. 1)
without aﬀecting levels of IES SUR2A and IES SUR2B (IES SUR2A cy-
cling threshold was 23.32 ± 0.10 for 2-deoxyglucose, n= 6,
P=0.124 when compared to controls; IES SUR2B cycling threshold
was 31.33 ± 0.11 for 2-deoxyglucose, n= 6, P=0.790 when com-
pared to controls; Fig. 1) and increasing levels of Kir6.2 (cycling
threshold was 26.43 ± 0.09 for 2-deoxyglucose, n= 6, P < 0.01
when compared to controls; Fig. 1). Cell culturing in the absence of
glucose signiﬁcantly decreased cellular resistance to DNP (10mM; cell
survival was 52.4 ± 2.7% for controls and 45.5 ± 1.9%; P < 0.01;
n=7; Fig. 1). Exposure to 2-deoxyglucose (50mM) signiﬁcantly de-
creased cell survival in DNP (10mM; cell survival was 38.5 ± 1.4% for
2-deoxyglucose; P < 0.01 when compared to controls and no glucose;
n= 7; Fig. 1). Further, we have examined the eﬀect of high glucose on
KATP channel subunits and DNP-induced challenge. Exposure of cells to
50mM glucose did not alter the levels of KATP channel subunits nor
aﬀected cellular resistance to DNP (10mM; Fig. 2).
3.2. Regulation of expression of KATP channel subunits in H9c2 cells and
cellular resistance to severe metabolic stress by insulin
Insulin activates PI3K/Akt signalling pathway which is known to
up-regulate SUR2A [23]. When insulin (20 ng/ml) was applied in the
presence of physiological glucose, it signiﬁcantly down-regulated
SUR2A (cycling threshold was 27.57 ± 0.15 without and
28.09 ± 0.17 with insulin, n= 12, P= 0.032; Fig. 3), did not aﬀect
expression of SUR2B, Kir6.2, SUR1, IES SUR2A and IES SUR2B (SUR2B:
cycling threshold was 21.47 ± 0.29 without and 21.59 ± 0.48 with
insulin, n= 10–12, P= 0.833; Kir6.2: cycling threshold was
27.57 ± 0.86 without and 27.28 ± 0.18 with insulin, n= 12,
P=0.175; SUR1: cycling threshold was 31.47 ± 0.20 without and
31.41 ± 0.25 with insulin, n= 12, P=0.856; IES SUR2A: cycling
threshold was 24.75 ± 0.65 without and 25.26 ± 0.94 with insulin,
n= 8–11, P=0.646; IES SUR2B: cycling threshold was 27.58 ± 1.06
without and 26.65 ± 1.12 with insulin, n= 8, P=0.558; Fig. 3). A
sole upregulated subunit was Kir6.1 (Kir6.1: cycling threshold was
20.39 ± 0.10 without and 19.99 ± 0.09 with insulin, n= 12,
P < 0.01; Fig. 3). Application of insulin (20 ng/ml) in the presence of
high glucose (50mM) also down-regulated SUR2A (cycling threshold
was 28.02 ± 0.08, n= 6, P < 0.01 when compared to control; Fig. 3)
and the only diﬀerence between action of insulin in the presence of
physiological (5 mM) and high (50mM) glucose was in the eﬀect on
Kir6.2, where insulin in high glucose (50mM) upregulated Kir6.2 (cy-
cling threshold was 25.90 ± 0.18, n=6, P < 0.01 when compared to
those in 5mM glucose; Fig. 3). Exposure of H9c2 cells to insulin (20 ng/
ml) in either physiological (5 mM) or high (50mM) glucose sig-
niﬁcantly decreased cell survival in DNP (10mM; cell survival was
48.8 ± 1.7% and 43.5 ± 3.7% when cell were cultured without in-
sulin in 5mM and 50mM glucose respectively, and 29.7 ± 6.7% and
24.0 ± 3.4% when cells were cultured in 20 ng/ml insulin in 5mM and
50mM glucose respectively, P < 0.01 when compared to corre-
sponding experimental group without insulin, n= 3–27, Fig. 3).
3.3. Regulation of cell resistance to DNP by SUR2A and Kir6.2
It has been shown previously that increased expression of SUR2A
protects adult cardiomyocytes as well as H9c2 cells against diﬀerent
types of stresses [13–16]. Here, we have tested whether infection with
diﬀerent titers of SUR2A alone or Kir6.2 alone would have any eﬀect on
survival of H9c2 cells when exposed to DNP (10mM). Infection with
Ad-Kir6.2 did not have any eﬀect on cellular survival (Fig. 4), while
infection with SUR2A demonstrated titre-dependent cytoprotection
(Fig. 4).
4. Discussion
In the present study we have shown that insulin decreases resistance
to metabolic stress in heart embryonic H9c2 cells by decreasing ex-
pression of SUR2A.
Insulin is known to activate PI3K/Akt signalling pathway and it was
logically to expect that insulin would up-regulate SUR2A as this is what
PI3K/Akt activation does [23]. However, the obtained eﬀect was op-
posite, i.e. insulin down-regulated SUR2A. Insulin has been suggested
to inhibit cardiomyocytes apoptosis [8], protects H9c2 cells against
doxorubicin toxicity [32], and decrease the size of myocardial infarc-
tion in whole heart ischaemia-reperfusion model [33]. In contrast, it
has been shown that insulin inhibits cardioprotection aﬀorded by
ischaemic preconditioning via Akt-dependent mechanisms [9]. In ad-
dition to that, there is a lot of clinical studies suggesting that insulin
therapy had either no eﬀect or worsened cardiovascular events [10,11].
SUR2A regulates cellular resistance to metabolic stress in both adult
cardiomyocytes and H9c2 cells [13–16]. The underlying mechanism of
cytoprotection aﬀorded by SUR2A seems to be associated with SUR2A-
mediated regulation of number of fully-assembled sarcolemmal KATP
channels [13]. A cardiac phenotype with increased SUR2A and channel
numbers is characterised by earlier activation of sarcolemmal KATP
channels in response to metabolic stress [13], which is similar to those
seen in preconditioning [34,35]. Also, SUR2A regulates levels of sub-
sarcolemmal ATP and this mechanism of cardioprotection is in-
dependent from the channel activity [14,36–38]. Besides eﬀects on
cellular level, SUR2A also have major eﬀects on whole organ and in
vivo levels. Mice with non-targeted expression of SUR2A are char-
acterised by increased physical endurance and slower decline in phy-
sical performance during ageing [15,16] and they seem to live sig-
niﬁcantly longer than wild type mice [40]. So far, ageing is identiﬁed as
the only condition that downregulates SUR2A and decreases cardiac
resistance to stress [16,41]. Observed insulin-induced decrease of
SUR2A in H9c2 cells is in agreement with experimental/clinical studies
reporting that insulin impairs cardioprotection. In further support of
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this notion is our ﬁnding that DNP, an inhibitor of oxidative phos-
phorylation, induced more cell deaths in insulin-treated cells than in
untreated ones. This is consistent with previous ﬁndings that lower
SUR2A levels are associated with increased susceptibility to ischaemia
and β-adrenergic stress [15,16,39–42]. Decrease in myocardial SUR2A
could explain negative cardiac events observed in insulin-treated dia-
betes type 2 patients [10,11] and shorter lifespan [43].
It is well established that insulin regulates expression of many genes
[2–5]. Here, we have shown that it also up-regulates Kir6.2. What are
consequences of such an eﬀect is yet unknown, but it is certain that, as
opposed to SUR2A, an increase of Kir6.2 alone does not regulate cel-
lular resistance to stress. Studies so far demonstrated that cellular re-
sistance follow up SUR2A levels even when expression of other genes is
altered [13–16,42]. Apart from SUR2A and Kir6.1, insulin did not aﬀect
expression of any other gene encoding sarcolemmal or mitochondrial
KATP channel-forming subunit showing that those are not insulin tar-
gets.
Many studies in the past demonstrated that the eﬀect of insulin is
inﬂuenced by the presence of glucose [2–5]. Therefore, we have as-
sessed whether high glucose would aﬀect insulin action on KATP
channel subunits expression. It has been previously shown that high
glucose activates KATP channels in cardiomyocytes via products of
glycolysis that act as channel openers [30,31]. However, high glucose
did not aﬀect expression of any of KATP channel-forming subunits nor
had any major inﬂuence on insulin-mediated regulation of channel
subunits or cell survival. These ﬁnding suggest that the observed insulin
eﬀect was glucose-independent. In contrast, a lack of any eﬀect on KATP
channel subunits expression by high glucose, no glucose or inhibition of
glycolysis down-regulated SUR2A. These ﬁndings were not that sur-
prising when considering that intracellular ATP regulates SUR2A ex-
pression [24]. As inhibition of glycolysis decrease intracellular ATP, our
ﬁndings that it also decreases SUR2A levels perfectly ﬁts into previously
published ﬁndings that SUR2A levels follow intracellular ATP levels
[24]. However, it is surprising that insulin would have similar eﬀect on
SUR2A expression and cellular susceptibility to metabolic stress as no
glucose and inhibition of glycolysis have. It is also interesting to note
Fig. 3. Insulin down-regulates SUR2A in H9c2 cells and decrease cellular resistance to metabolic stress. Bar graphs represent cycling thresholds of the real time RT-
PCR progress curves of KATP channel subunits as labelled and a bar graph (a graph on the right third row) showing a percentage of survival in control cells and cells
cultured with insulin (20 ng/ml) (insulin) or cells cultured with insulin (20 ng/ml) in the presence of 50mM glucose exposed to DNP (10mM). Each bar represent
mean± SEM (n=3–27). *P < 0.05 when compared to control.
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that insulin regulated levels of SUR2A alone without aﬀecting levels of
SUR2B, IES SUR2A and IES SUR2B. As all these proteins are products of
a single gene, this would imply that insulin could act on splicing me-
chanism as well. However, this is not certain. It is interesting to note
that many conditions regulate SUR2A or SUR2B or IES SUR2A/B levels
alone without aﬀecting other products of ABCC9 gene
[15,16,22,39,44]. Thus, a selective regulation of a single ABBC9 pro-
duct is not unusual at all and this is a phenomenon worthwhile to be
understood.
Insulin-induced decrease in cardiac SUR2A is previously un-
recognised eﬀect that should be seriously taken into account in the
future. Lower SUR2A levels are likely to be associated with increased
myocardial susceptibility to metabolic stress, decreased physical en-
durance and lifespan [15,39]. Recognising decrease in myocardial
SUR2A as a consequence of therapy with insulin would be crucial, as
there are safe compounds/strategies that could be clinically im-
plemented to up-regulate SUR2A [15,39].
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